Patent Baristas

Former Secretary of Health and Human Services to Lead Panel at 2012 BIO International Convention Panel Calls for the Urgent Need to Better Fuel the Biotechnology Pipeline with a Diverse Workforce WHAT:                Thought leaders of industry, education, and government will gather to discuss fostering and recruiting a more diverse workforce in the biotechnology industry at [...]

The Biotechnology Industry Organization (BIO) will take the wraps off some findings from a report on the role of Intellectual Property Rights (IPRs) in encouraging upstream R&D and downstream commercialization in biotechnology at the 2012 BIO International Convention in Boston. “Taking Stock: the Gains of Global Biotechnology Research from IPRs” The report, titled “Taking Stock: [...]

The 2012 BIO International Convention will feature an educational track devoted to Biotech Patenting and Tech Transfer to discuss legal and legislative developments and how they are likely to impact biotech companies.   Hosted by the Biotechnology Industry Organization(BIO), this year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and [...]

What: Known by many names within the industry – non-practicing entity (NPE), patent assertion entity (PAE) and most infamously as “patent trolls” – NPEs over the past few years have single-handedly spawned a sub-specialty of patent litigation.  It’s certainly big business.  It’s estimated that the average patent suit involving NPEs results in $122 million in [...]

United States Patent and Trademark Office (USPTO), Invent Now® and the National Academy of Inventors™ invite you to the Florida Regional Inventors Conference, a great chance to get practical advice from expert USPTO staff and to network with fellow creative entrepreneurs. Space is limited, so click here to register early. The conference will be held [...]

6th Annual Paragraph IV Disputes Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics April 24-25, 2012 Workshops: April 23 and 26, 2012 Marriott New York Downtown New York City Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather in New York City at American Conference Institute’s (ACI’s) [...]

What: The only event where the industry leaders driving the business of biosimilars come together to set the standards shaping the rapidly evolving legal and regulatory landscape. Whether you are on the branded or generic side, you cannot afford to miss this opportunity because you will: Hear directly from the FDA on how they will [...]

What: American Conference Institute’s FDA Boot Camp.  Basic training in core regulatory concepts for life sciences lawyers, business executives and policy analysts The approval process…pre-approval concerns…product labeling…clinical trials…adverse events reports…patent concerns…exclusivity. — all are critical aspects in the commercialization process for drugs, biologics, and devices which are governed by FDA law and regulation. Recent court [...]